CytoMed Therapeutics Limited - Ordinary Shares
GDTC40
$2.56arrow_drop_up4.91%$0.12
Penny Stock
GDTC40
$2.56
arrow_drop_up4.91%Performance History
| Key Stats | |
|---|---|
| Open | $2.47 |
| Prev. Close | $2.44 |
| EPS | -0.22 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $29.54M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 2.38 | 2.62 |
| 52 Week Range | 1.20 | 5.50 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | -0.22 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About CytoMed Therapeutics Limited - Ordinary Shares (GDTC)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Headquarters
- Singapore
- Employees
- 0
- Exchange
- NASDAQ
Keep an eye on CytoMed Therapeutics Limited - Ordinary Shares
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is the 52-week high and low for CytoMed Therapeutics Limited - Ordinary Shares (GDTC)?
For CytoMed Therapeutics Limited - Ordinary Shares (GDTC), the 52-week high is $5.5, which is 114.84% from the current price. The 52-week low is $1.2, the current price is 113.33% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
What is CytoMed Therapeutics Limited - Ordinary Shares's (GDTC) price per share?
The current price per share for CytoMed Therapeutics Limited - Ordinary Shares (GDTC) is $2.56. The stock has seen a price change of $0.12 recently, indicating a 4.92% change. This reflects the stock's recent market performance and investor sentiment.
help
Is CytoMed Therapeutics Limited - Ordinary Shares (GDTC) a growth stock?
CytoMed Therapeutics Limited - Ordinary Shares (GDTC) has shown an average price growth of -4.38% over the past three years. It has received a score of 6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying CytoMed Therapeutics Limited - Ordinary Shares as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is CytoMed Therapeutics Limited - Ordinary Shares (GDTC) stock price performance year to date (YTD)?
As of the latest data, CytoMed Therapeutics Limited - Ordinary Shares (GDTC) has a year-to-date price change of -41.95%. Over the past month, the stock has experienced a price change of 15.83%. Over the last three months, the change has been 68.42%. Over the past six months, the figure is 33.33%.
help
Is CytoMed Therapeutics Limited - Ordinary Shares (GDTC) a profitable company?
CytoMed Therapeutics Limited - Ordinary Shares (GDTC) has a net income of -$3.13M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 73.34% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -735.97% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 7.48%, providing insight into the company's sales performance and growth. The gross profit is $213.09K. Operating income is noted at -$2.91M. EBITDA information is currently not available.
help
What is the market capitalization of CytoMed Therapeutics Limited - Ordinary Shares (GDTC)?
CytoMed Therapeutics Limited - Ordinary Shares (GDTC) has a market capitalization of $29.54M. The average daily trading volume is 2.57, indicating the stock's liquidity and investor engagement.